About the book
During the last years, there was intense research on Ankylosing Spondylitis (AS) and related disorders, which were found to have a strong association with the HLA-B27 allele. Further studies showed that 92% of the population variance is due to genetic factors, and only a fraction of AS genetics can be explained by the influence of HLA-B27. Updated information on the genomic and auto-immune knowledge on AS is an important component of this book, calling attention to markers of disease activity, possible pathways, and the interaction with the gut microbiome, which are a step forward in the knowledge of the pathophysiology of AS, providing markers which are targets for the more recent biologic therapies.
An update on clinical manifestations, their assessment, monitoring, and imagiology, including peripheral arthritis, enthesopathy, and extra-articular findings, and, the differential diagnosis with other diseases which evolves with axial and peripheral calcifications will be provided.
An important component of this book must be dedicated to the more recent treatments namely with biologic therapies but focusing also on new small molecule inhibitors and experimental therapies.